Arabic Patient-reported Outcome Measures During Radiotherapy for Head and Neck Cancer: a Validation Study

Status: Recruiting
Location: See location...
Intervention Type: Radiation
Study Type: Observational
SUMMARY

The goal of Arabic patient-reported outcome measures during radiotherapy for head and neck cancer is to test the patient-reported outcome measure (PROM) tools. PROM tools are not validated cross-culturally in Arabic-speaking patient populations, which limits their use in our clinical setting. Validation of these PROM tools will allow clinicians to identify the concerns related to our patient population and measure the outcome of our interventions. Main objectives are: * To further validate (cross-culture) the PROM instruments related to head and neck cancer (HNC) in Arabic patients. * To investigate the prevalence and severity of the patient-reported concerns and their relevance with demographics and clinical characteristics. The participants will be given tasks to complete 6 tools survey before, during, and after radiotherapy.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Adults aged 18 or above and who is planned for receiving and who is currently receiving and who had already received radiotherapy for the HNC at King Saud University Medical City.

Locations
Other Locations
Saudi Arabia
King Saud University Medical City
RECRUITING
Riyadh
Contact Information
Primary
Abdullah M Alsoghier, PhD
aalsoghier@ksu.edu.sa
+966114677423
Backup
Saif A Aljabab, DABR
saljabab@ksu.edu.sa
Time Frame
Start Date: 2023-05-01
Estimated Completion Date: 2025-10-01
Participants
Target number of participants: 125
Treatments
Adult aged 18 years or above, and receiving radiotherapy for the HNC.
A non-interventional, questionnaire-based cross-sectional study for Arabic-speaking males and females, aged 18 years or above who is planned for receiving and who is currently receiving and who had already received radiotherapy for the Head \& Neck Cancer at King Saud University Medical City.
Sponsors
Leads: King Saud University

This content was sourced from clinicaltrials.gov